U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07012512) titled 'Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children' on May 30.
Brief Summary: The study aims at reversing pupillary dilatation. and cycloplegia in children undergoing cycloplegic refraction for eyeglasses prescription and ocular examination. This will be achieved using pilocarpine , phentolamine or a combination. This may help decrease the glare and improve near vision early to decrease unwanted effects of cycloplegic drops.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Pupillary Constriction
A...